Refine
Has Fulltext
- yes (15)
Is part of the Bibliography
- yes (15)
Document Type
- Journal article (15)
Language
- English (15) (remove)
Keywords
- prostate cancer (7)
- radioligand therapy (5)
- PSMA (3)
- PET/CT (2)
- PSMA I&T (2)
- angiogenesis (2)
- biomarker (2)
- kidney cancer (2)
- machine learning (2)
- 68Ga-PSMA ligand PET/CT (1)
- CTCAE (1)
- Cancer Cell (1)
- PSA (1)
- PSA response (1)
- PSMA-617 (1)
- PSMA-RADS (1)
- PSMA-TV (1)
- PSMA‐617 (1)
- RCC (1)
- RLT (1)
- SOAT1 (1)
- SUV (1)
- Sunitinib (1)
- Tyrosine kinase inhibition (1)
- [177Lu]Lu-PSMA I&T (1)
- \(^{177}\)Lu (1)
- \(^{18}\)F-PSMA-1007 (1)
- agreement (1)
- androgen deprivation therapy (1)
- cholesterol metabolism (1)
- comparability (1)
- detection rate (1)
- flare phenomenon (1)
- hematotoxicity (1)
- high-risk Prostate Cancer (1)
- immune infiltration (1)
- late response (1)
- mRNA (1)
- mTOR (1)
- matched pair (1)
- metabolic tumour volume (MTV) (1)
- miR (1)
- miRNA (1)
- microRNA-221 (1)
- mitochondrial DNA (1)
- mtDNA (1)
- nephrotoxicity (1)
- overall survival (1)
- pan-RCC (1)
- prediction (1)
- prostate-specific membrane antigen (1)
- prostate-specific membrane antigen (PSMA) (1)
- recurrent prostate cancer (1)
- risk stratification (1)
- software (1)
- staging (1)
- standardized reporting system (1)
- taxane (1)
- theranostics (1)
- total lesion PSMA (1)
- transcriptome (1)
- tumor microenvironment (1)
- venous infiltration (1)
Institute
- Urologische Klinik und Poliklinik (15)
- Klinik und Poliklinik für Nuklearmedizin (10)
- Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie (4)
- Comprehensive Cancer Center Mainfranken (3)
- Pathologisches Institut (3)
- Theodor-Boveri-Institut für Biowissenschaften (3)
- Center for Computational and Theoretical Biology (2)
- Institut für diagnostische und interventionelle Radiologie (Institut für Röntgendiagnostik) (1)
- Medizinische Klinik und Poliklinik I (1)
- Medizinische Klinik und Poliklinik II (1)
(1) Background: Clear cell renal cell carcinoma extending into the inferior vena cava (ccRCC\(^{IVC}\)) represents a clinical high-risk setting. However, there is substantial heterogeneity within this patient subgroup regarding survival outcomes. Previously, members of our group developed a microRNA(miR)-based risk classifier — containing miR-21-5p, miR-126-3p and miR-221-3p expression — which significantly predicted the cancer-specific survival (CSS) of ccRCC\(^{IVC}\) patients. (2) Methods: Examining a single-center cohort of tumor tissue from n = 56 patients with ccRCC\(^{IVC}\), we measured the expression levels of miR-21, miR-126, and miR-221 using qRT-PCR. The prognostic impact of clinicopathological parameters and miR expression were investigated via single-variable and multivariable Cox regression. Referring to the previously established risk classifier, we performed Kaplan–Meier analyses for single miR expression levels and the combined risk classifier. Cut-off values and weights within the risk classifier were taken from the previous study. (3) Results: miR-21 and miR-126 expression were significantly associated with lymphonodal status at the time of surgery, the development of metastasis during follow-up, and cancer-related death. In Kaplan–Meier analyses, miR-21 and miR-126 significantly impacted CSS in our cohort. Moreover, applying the miR-based risk classifier significantly stratified ccRCC\(^{IVC}\) according to CSS. (4) Conclusions: In our retrospective analysis, we successfully validated the miR-based risk classifier within an independent ccRCC\(^{IVC}\) cohort.